NYSE: CLOSED
TSE: CLOSED
LSE: CLOSED
HKE: CLOSED
NSE: CLOSED
BM&F: CLOSED
ASX: CLOSED
FWB: CLOSED
MOEX: CLOSED
JSE: CLOSED
DIFX: CLOSED
SSE: CLOSED
NZSX: CLOSED
TSX: CLOSED
SGX: CLOSED
NYSE: CLOSED
TSE: CLOSED
LSE: CLOSED
HKE: CLOSED
NSE: CLOSED
BM&F: CLOSED
ASX: CLOSED
FWB: CLOSED
MOEX: CLOSED
JSE: CLOSED
DIFX: CLOSED
SSE: CLOSED
NZSX: CLOSED
TSX: CLOSED
SGX: CLOSED
By Metal or Resource
By Project Stage
By Exchange
By Geography
By Investment Theme
CRISM Therapeutics Corp
Crux Investor Index
3
–
Market Cap (USD)
8380000
Symbol
LSE:AMC
Stage of development
Primary COMMODITY
Nickel
Additional commodities
Copper
Article
CRISM Therapeutics Corp Analyst Notes
No analyst notes
Company Resources
Submitted by
CRISM Therapeutics Corp
Charts
Stay Informed
Sign up for our FREE Monthly Newsletter, used by +45,000 investors
By clicking send you'll receive occasional emails from Crux Investor. You always have the choice to unsubscribe within every email you receive.
